U of A professor of medical genetics Toshifumi Yokota and the Yokota Lab are making advancements in gene therapy.

HT-KIT is engineered to selectively bind to mutant KIT mRNA transcripts and block their translation, thereby preventing the production of the KIT protein, a critical driver of tumor growth in cancers ...